InvestorsHub Logo
Followers 16
Posts 1063
Boards Moderated 0
Alias Born 09/01/2019

Re: nelskof post# 31169

Monday, 11/23/2020 1:32:53 PM

Monday, November 23, 2020 1:32:53 PM

Post# of 44690
30K doses by March will treat 10000 severely ill patients. Now that is Finally doing Something.
The talk of equal price to Rem for treatment courses conflicts with the statement of easy production and low costs.?. That is for the IV?
Maybe this is the start of Partnerships and requests for the Drug Dr J also talked about recently.
The Inhaled version with the ease of application seems the needed target to expedite into the start of their clinical Trials whether here or in Eu / Israel.
The additional shares may be also to finance this. Maybe they are also for working the NRX IPO and bringing RLF into that new entity.
A R/S leaves the MC the same but will consolidate everything with an updated collective NRX/RLF proxy for the future. GEM/Insiders have control thru the Large holdings and I expect a surprise. No vote by common shareholders is really necessary, IMO...